Success Story: RFE Conquered: NAILG Secures EB1A Approval for Scientist Advancing Gut Health and Food Safety, Following Prior NIW Success
Client’s Testimonial:
“Everything went smoothly from day one. The instructions were clear, and the lawyers went above and beyond to ensure every detail was included. I have already recommended your firm to a couple of my friends, and 3 of them got a contract/filed with your firm, and they were happy about the process as well!”
On August 27th, 2024, and September 10th, 2025, we received I-140 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approvals for a Postdoctoral Researcher in the Field of Poultry Science (Approval Notice).
General Field: Poultry Science
Position at the Time of Case Filing: Postdoctoral Researcher
Country of Origin: Lebanon
State of Residence at the Time of Filing: Georgia
Approval Notice Date: August 27th, 2024 (NIW); September 10th, 2025 (EB1A)
Processing Time: 5 months, 13 days (NIW); 2 months, 28 days (EB1A, Premium Processing Requested)
Case Summary:
A distinguished researcher specializing in gut microbiology, nutrition, and immunology, our client has played a pivotal role in advancing scientific understanding of infectious diseases in poultry and their implications for global food safety. With the support of the North America Immigration Law Group (NAILG), he secured both EB2-NIW and EB1A (Alien of Extraordinary Ability) approvals, an achievement that reflects the national and international significance of his research.
The client’s NIW petition was approved on August 27th, 2024, followed by an EB1A approval on September 10th, 2025, after a brief RFE review. Both petitions highlighted his proven track record of scientific leadership, innovation, and broad influence within the poultry science community.
Pioneering Research and Impactful Contributions
Holding a Ph.D. in Poultry Sciences, the petitioner has built a career focused on addressing some of the most pressing challenges in animal health and food security. His investigations have yielded novel insights into the mechanisms of necrotic enteritis, the benefits of synbiotic supplementation as an antibiotic alternative, and the development of safer, nanoparticle-based vaccines against Salmonella infection.
His scholarly record includes 22 peer-reviewed journal articles (6 first-authored) and 21 conference abstracts, with a total of 312 independent citations, placing several of his papers among the top 1% most-cited works in agricultural science. His findings have been published in top-tier journals. Furthermore, he has conducted at least 23 peer reviews for leading scientific journals, underscoring his recognition as a trusted authority in his field.
A leading expert summarized his contributions as follows:
“It is clear that [Client] is a respected poultry science researcher who has uncovered the pathogenic mechanisms of necrotic enteritis in chickens, shown the benefits of synbiotic treatment, and achieved an extensive publication record in high-quality venues.”
EB1A Approval and Outlook
NAILG’s comprehensive legal approach emphasized both the originality and real-world impact of the client’s research. Our team successfully demonstrated that his innovations represent original contributions of major significance and that his work has achieved sustained national and international acclaim.
With both NIW and EB1A petitions approved, this dual success highlights not only the petitioner’s remarkable career trajectory but also NAILG’s expertise in securing approvals for scientists whose research strengthens U.S. leadership in food safety, animal health, and agricultural sustainability.